Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 21 (5%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 382 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PROGESTERONE | 100MG | CAPSULE | Resolved | 2023-08-29 | 2023-09-25 | 203121 |
| BACLOFEN | 20MG | TABLET | Resolved | 2023-08-29 | 2023-09-25 | 203125 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
| PREGABALIN | 75MG | CAPSULE | Resolved | 2023-08-29 | 2023-11-06 | 203135 |
| METFORMIN | 500MG | TABLET | Resolved | 2023-08-29 | 2023-09-19 | 203144 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2023-09-26 | 2023-12-01 | 205212 |
| GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-10-23 | 2024-04-04 | 207850 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
| PREGABALIN | 150MG | CAPSULE | Resolved | 2023-10-23 | 2023-12-01 | 207862 |
| PREGABALIN | 25MG | CAPSULE | Resolved | 2023-10-23 | 2024-03-09 | 207865 |
| VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207872 |
| VALACYCLOVIR | 500MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207875 |
| CANDESARTAN | 32MG | TABLET | Resolved | 2023-10-23 | 2024-03-11 | 207878 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| TRAZODONE | 50MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207906 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
| PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-11-22 | 2023-12-26 | 211037 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-11-22 | 2024-01-30 | 211052 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| TERAZOSIN | 10MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151275 |
| TERAZOSIN | 1MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151278 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |